// App-Quantinova.ai

Mo1649 : CDK10, a Potential Predictive Biomarker for Colorectal Cancer, Is Involved in BCL-2 and BCL-XL Mediated-Resistance to Apoptosis

Researchers

Presenter

  • Mohammad Hasan

Principal Investigators

  • Yaling Yin

  • David F. Schaeffer

  • Hagen Kennecke

  • Isabella T. Tai

Medical Centers

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

  • Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • B-cell lymphoma 2

  • Cyclin dependent kinase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved